IN8BIO, INC. Operating Loss Carryforwards
IN8BIO, INC. (INAB) had Operating Loss Carryforwards of $92.10 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Operating Loss Carryforwards $92.10M.
- 2024-12-31: Operating Loss Carryforwards $69.80M.
- 2023-12-31: Operating Loss Carryforwards $52.40M.
- 2022-12-31: Operating Loss Carryforwards $36.60M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $92.10M 10-K · filed 2026-03-12 |
| 2024-12-31 | $69.80M 10-K · filed 2025-03-13 |
| 2023-12-31 | $52.40M 10-K · filed 2024-03-14 |
| 2022-12-31 | $36.60M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |